High-resolution NMR and computer modeling studies of the cannabimimetic aminoalkylindole prototype WIN-55212-2

Journal of Medicinal Chemistry

Volumn 42, Issue 20, 1999, Pages 4021-4027

  Xie, Xiang Qun ^a   Han, Xiu Wen ^a,c   Chen, Jian Zhong ^a   Eissenstat, Michael ^b   Makriyannis, Alexandros ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b SAIC FREDERICK INC   (United States)

^c DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; CANNABINOID RECEPTOR; CANNABINOID RECEPTOR AGONIST; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANTINOCICEPTION; ARTICLE; COMPUTER MODEL; COMPUTER SIMULATION; DRUG CONFORMATION; DRUG DESIGN; DRUG RECEPTOR BINDING; DRUG STRUCTURE; NUCLEAR MAGNETIC RESONANCE IMAGING; STRUCTURE ANALYSIS;

CANNABINOIDS; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MORPHOLINES; NAPHTHALENES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG;

EID: 0033533864     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980592k     Document Type: Article

References (27)

1. Bell, M. R.; D'Ambra, T. E.; Kumar, V.; Eissenstat, M. A.; Hermann, J. L.; Wetzel, J. R. Jr.; Rosi, D.; Philion, R. E.; Daum, S. J.; Hlasta, D. J.; Kulling, R. K.; Ackerman, J. H.; Haubrich, D. R.; Luttinger, D. A.; Baizman, E. R.; Miller, M. S.; Ward, S. J. Antinociceptive (aminoalkyl) indoles. J. Med. Chem. 1991, 34, 1099-1100.
2. Pacheco, M.; Childers, S. R.; Arnold, R.; Casinao, F.; Ward, S. J. Aminoalkylindoles: actions on specific G-protein-linked receptors. J. Pharmacol. Exp. Ther. 1991, 257, 170-183.
3. Ward, S. J.; Mastriani, D.; Casino, F.; Arnold, R. Pravadoline: profile in isolated tissue preparations. J. Pharmacol. Exp. Ther. 1990, 255, 1230-1239.
4. D'Ambra, T. E.; Estep, K G.; Bell, M. R.; Eissenstat, M. A.; Josef, K. A.; Ward, S. J.; Haycock, D. A.; Baizman, E. R.; Casiano, F. M.; Beglin, N. C.; Chippari, S. M.; Grego, J. D.; Kullnig, R. K.; Daley, G. T. Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (Aminoaklyl) indole Agonists of the Cannabinoid Receptor. J. Med. Chem. 1992, 35, 124-135.
5. Devane, W. A.; Dysarz III, F. A.; Johnson, M. R.; Melvin, L. S.; Howlett, A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605-613.
6. Hlasta, D. J.; Luttinger, D.; Perrone, M. H.; Silbernagel, M. J.; Ward, S. J. Alpha 2-adrenergic agonists/antagonists: the synthesis and structure-activity relationships of a series of indolin-2-yl and tetrahydroquinolin-2-yl imidazolines. J. Med. Chem. 1987, 30, 1555-1562.
7. Huffman, J. W.; Dai, D.; Martin, B. R.; Compton, D. R. Design, synthesis and pharmacology of cannabinoid indoles. Bioorg. Med. Chem. Lett. 1994, 4, 563-56.
8. Eissenstat, M. A.; Bell, M. R.; D'Ambra, T. E..; Estep, K.; Haycock, D. A.; Olefirowicz, E. M.; Ward, S. J. Aminoalkylindoles (AAIs): structurally novel cannabinoidminetics. NIDA Res. Monogr. Ser. No. 105 1991, 427.
9. Thomas, B. F.; Compton, D. R.; Martin, B. R.; Semus, S. F. Modeling the cannabinoid receptor: A three-dimensional quantitative structure-activity analysis. Mol. Pharmacol. 1991, 40, 656-665.
10. Reggio, P. H.; Basu-Dutt, S.; Hurst, D. P.; Patel, M. J.; Seltzman, H. H.; Thomas, B. F. What is the bioactive conformation of aminoalkylindoles at the CB1 receptor? insights gained from the E and Z naphthylidenes. International Cannabinoid Research Society, June 1997.
11. Xie, X. Q.; Eissenstat, M. A.; Makriyannis, A. Common cannabimimetic pharmacophoric requirements between aminoalkyl indoles and classical cannabinoids. Life Sci. 1995, 56, 1963-1970.
12. (a) Makriyannis, A.; Rapaka, R. S. The molecular basis of cannabinoid activity. Life Sci. 1990, 47, 2173-2184.
13. (b) Makriyannis, A. The role of cell membranes in cannabinoid activity. In The Cannabinoid Receptors; Pertwee, R. G., Ed.; Academic Press: London, U.K., 1996; pp 87-116.
14. Song, Z. H.; Bonner, T. I. A Lysine reside of the cannabinoid receptor is critical for receptor recoginition by several agonists but not WIN55212-2. Mol. Pharmacol. 1996, 49, 891-896.
15. Shire, D.; Calandra, B.; Delphech, M.; Dumont, X.; Kaghad, M.; Le Fur, G.; Caput, D.; Ferrara, P. Structural Features of the Central Cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR141716A. J. Biol. Chem. 1996, 271, 6941-6946.
16. 1H spin-spin coupling constants in proteins. Biochem. Biophys. Res. Commun. 1983, 113, 967-974.
17. Bodenhausen, G.; Kogler, H.; Ernst, R. R. Selection of coherence transfer pathways in NMR pulse experiments. J. Magn. Reson. 1984, 58, 370-388.
18. Bax, A.; Subramanian, S. Sensitivity-enhanced 2D heteronuclear shift correlation NMR spectroscopy, J. Magn. Reson. 1986, 67, 565-569.
19. Ruiz-Cabello, J.; Vuister, G. W.; Moonen, C. T. W.; Gelderen, P. V.; Cohen, J. S.; van Zijl, P. C. M. Gradient-enhanced heteronuclear correlation spectroscopy. Theory Exp. Aspects 1992, 700, 282-302.
20. SYBYL (version 6.4) molecular modeling software packages from TRIPOS Associates, Inc., St. Louis, MO 63144.
21. Hagler, A. T. Theoretical simulation of conformation, energetics, and dynamics of peptides. In The Peptides: Conformation in Biology and Drug Design; Udenfriend, S., Meienhofer, J., Eds.; Academic Press: New York, 1985; pp 214-300.
22. Xie, X. Q.; Melvin, L. S.; Makriyannis, A. The Conformational Properties of the Highly Selective Cannabinoid Receptor Ligand CP-55,940. J. Biol. Chem. 1996, 277, 10640.
23. Dewar, M. A.; Zoebisch, E. G.; Healy, E. F.; Stewart, J. P. AM1, A New General Purpose Quantum Mechanical Molecular Mode. J. Am. Chem. Soc. 1985, 707, 3902-3909.
24. Xie, X. Q.; Yang, D. P.; Melvin, L. S.; Makriyannis, A. Conformational analysis of a prototype nonclassical cannabinoid CP-47,497 using 2D NMR and computer molecular modeling. J. Med. Chem. 1994, 47, 1418-1426.
25. Kriwacki, R. W.; Makriyannis, A. The conformational analysis of Δ9-and Δ9,11-tetrahydrocannabinols in solution using high-resolution nuclear magnetic resonance spectroscopy. Mol. Pharmacol. 1989, 35, 495-503.
26. Reggio, P. H.; Greer, K. V.; Cox, S. M. The importance of the orientation of the C9 substituent to cannabinoid activity. J. Med. Chem. 1989, 32, 1630-1635.
27. Makriyannis, A. The role of the phenolic hydroxyl group during the tetrahydro-cannabinol:membrane interactions. In Marijuana: An International Research Report; Chesher, G., Consroe, P., Musty, R., Eds.; Australian Publishing Service: Canberra, 1988; pp 437-451.